5van Boxel-Dezaire AHH, Smits M, van Trigt-Hoff SCJ, et al.Cytokine and IL-12 receptor mRNA discriminate between different clinical subtypes in multiple sclerosis.J Neuroimmunol, 2001, 12: 152-160. 被引量：1
6Hainas JL, Bradford T, Garcia ME, et al.Multiple susceptibility loci for multiple sclerosis.Hum Mol Genet, 2002, 11: 2251-2256. 被引量：1
7Schmidt S, Barcellos LF, Desombre K.Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis.AM J Hm Genet, 2002, 70: 708-717. 被引量：1
8Soderstrom M, Jin YP, Hillert J, et al.Optic neuritis: prognosis for multiple sclerosis from MRI CSF and HLA findings.Neurology, 1998, 50: 708-714. 被引量：1
9McDonald WI, Compston A, Edan G, et al.Recommen-ded diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis.Ann Neurol, 2001, 50: 121-127. 被引量：1
10CHAMPS Study Group.Interferon beta-la for optic neuritis patients at high risk for multiple sclerosis.Am J Ophthalmol, 2001, 132: 463-471. 被引量：1
